Skip to Main Content

Paper Details

A combination of TERT promoter mutation and MGMT methylation status predicts clinically relevant subgroups of newly diagnosed glioblastomas.
Acta Neuropathol Commun
175
2016
Author NameAffiliation
Naoki ShinojimaKumamoto University
Motoo NaganeKyorin University Faculty of Medicine
Ryo NishikawaSaitama Medical University International Medical Center
  • 1 - 3

Datasets

Release 1.2